These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10354610)

  • 21. Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.
    Tomitaka S; Hashimoto K; Narita N; Minabe Y; Tamura A
    Eur J Pharmacol; 1995 Oct; 285(2):207-11. PubMed ID: 8566141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release.
    Homayoun H; Stefani MR; Adams BW; Tamagan GD; Moghaddam B
    Neuropsychopharmacology; 2004 Jul; 29(7):1259-69. PubMed ID: 15010696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA receptor inhibition prevents tolerance to cocaine.
    De Montis MG; Devoto P; Meloni D; Gambarana C; Giorgi G; Tagliamonte A
    Pharmacol Biochem Behav; 1992 May; 42(1):179-82. PubMed ID: 1356273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
    Kim HS; Rhee GS; Oh S; Park WK
    Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
    Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.
    Pierce RC; Meil WM; Kalivas PW
    Psychopharmacology (Berl); 1997 Sep; 133(2):188-95. PubMed ID: 9342786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior.
    Cornish JL; Duffy P; Kalivas PW
    Neuroscience; 1999; 93(4):1359-67. PubMed ID: 10501460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists.
    Biała G; Kotlińska J
    Alcohol Alcohol; 1999; 34(2):175-82. PubMed ID: 10344778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dizocilpine maleate, an N-methyl-D-aspartate antagonist, inhibits dipsogenic responses and C-Fos expression induced by intracerebral infusion of angiotensin II.
    Xu Z; Lane JM; Zhu B; Herbert J
    Neuroscience; 1997 May; 78(1):203-14. PubMed ID: 9135101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMDA receptor antagonism disrupts acquisition and retention of the context preexposure facilitation effect in adolescent rats.
    Heroux NA; Robinson-Drummer PA; Rosen JB; Stanton ME
    Behav Brain Res; 2016 Mar; 301():168-77. PubMed ID: 26711910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct gene expression profiles in adult rat brains after acute MK-801 and cocaine treatments.
    Storvik M; Tiikkainen P; van Iersel M; Wong G
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):211-9. PubMed ID: 16242920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor antagonist MK-801 selectively impairs learning of the contiguity of the conditioned stimulus and unconditioned stimulus in goldfish.
    Xu X
    Pharmacol Biochem Behav; 1997 Oct; 58(2):491-6. PubMed ID: 9300610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy.
    Livezey RT; Pearce LB; Kornetsky C
    Brain Res; 1995 Sep; 692(1-2):93-8. PubMed ID: 8548325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA and dopamine D1 receptors within NAc-shell regulate IEG proteins expression in reward circuit during cocaine memory reconsolidation.
    Li Y; Ge S; Li N; Chen L; Zhang S; Wang J; Wu H; Wang X; Wang X
    Neuroscience; 2016 Feb; 315():45-69. PubMed ID: 26674058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural sensitization to cocaine is dissociated from changes in striatal NMDA receptor levels.
    Szumlinski KK; Herrick-Davis K; Teitler M; Maisonneuve IM; Glick SD
    Neuroreport; 2000 Aug; 11(12):2785-8. PubMed ID: 10976963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation.
    Bast T; Zhang WN; Feldon J
    Hippocampus; 2003; 13(6):657-75. PubMed ID: 12962312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
    J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquisition, extinction, and reinstatement of Pavlovian fear conditioning: the roles of the NMDA receptor and nitric oxide.
    Johnson DM; Baker JD; Azorlosa JL
    Brain Res; 2000 Feb; 857(1-2):66-70. PubMed ID: 10700553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade.
    Papa SM; Boldry RC; Engber TM; Kask AM; Chase TN
    Brain Res; 1995 Dec; 701(1-2):13-8. PubMed ID: 8925275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.
    Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL
    Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.